Literature DB >> 2073092

Carrageenan-induced intestinal injury in the rat--a model for inflammatory bowel disease.

T N Moyana1, J M Lalonde.   

Abstract

The cause of inflammatory bowel disease (IBD) remains unknown. In this report, an attempt is made to produce a suitable animal model for studying the pathobiology of IBD, especially its pathogenesis. Sprague-Dawley rats were divided into four groups of six (A, B, C, D). The experimental design involved prior parenteral sensitization of groups A and B by a 1.5 percent solution of lambda degraded carrageenan followed by oral administration of the same solution for 30 days to groups A and C. The animals were then sacrificed, and the small intestine was evaluated for injury. Oral carrageenan caused significant intestinal injury as evidenced by ulceration, abnormal villous pattern, degree and extent of inflammation [p = 0.0001 for groups (A + C) versus (B + D)]. Prior sensitization aggravated the effects of oral carrageenan. Overall, the inflammation produced was reminiscent of human IBD in that there was pin-point ulceration, focality of lesions and lymphoid hyperplasia with microgranulomas. It was concluded that this carrageenan model may prove to be particularly useful for studying the pathobiology of human IBD.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2073092

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  7 in total

Review 1.  Oral tolerance in disease.

Authors:  P Garside; A M Mowat; A Khoruts
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

Review 2.  Combinatorial effects of diet and genetics on inflammatory bowel disease pathogenesis.

Authors:  Laura J Dixon; Amrita Kabi; Kourtney P Nickerson; Christine McDonald
Journal:  Inflamm Bowel Dis       Date:  2015-04       Impact factor: 5.325

3.  Carrageenan-induced innate immune response is modified by enzymes that hydrolyze distinct galactosidic bonds.

Authors:  Sumit Bhattacharyya; Haiying Liu; Zhenqing Zhang; Murielle Jam; Pradeep K Dudeja; Gurvan Michel; Robert J Linhardt; Joanne K Tobacman
Journal:  J Nutr Biochem       Date:  2009-10-28       Impact factor: 6.048

4.  Carrageenan inhibits granzyme A-induced detachment of and interleukin-8 release from alveolar epithelial A549 cells.

Authors:  Yumiko Yoshikawa; Hirofumi Hirayasu; Satoshi Tsuzuki; Tohru Fushiki
Journal:  Cytotechnology       Date:  2008-11-06       Impact factor: 2.058

Review 5.  Deregulation of intestinal anti-microbial defense by the dietary additive, maltodextrin.

Authors:  Kourtney P Nickerson; Rachael Chanin; Christine McDonald
Journal:  Gut Microbes       Date:  2015

Review 6.  A review on chemical-induced inflammatory bowel disease models in rodents.

Authors:  Puneet Kaur Randhawa; Kavinder Singh; Nirmal Singh; Amteshwar Singh Jaggi
Journal:  Korean J Physiol Pharmacol       Date:  2014-08-13       Impact factor: 2.016

7.  Lambda-carrageenan treatment exacerbates the severity of cerebral malaria caused by Plasmodium berghei ANKA in BALB/c mice.

Authors:  Frances C Recuenco; Ryo Takano; Shiori Chiba; Tatsuki Sugi; Hitoshi Takemae; Fumi Murakoshi; Akiko Ishiwa; Atsuko Inomata; Taisuke Horimoto; Yoshiyasu Kobayashi; Noriyuki Horiuchi; Kentaro Kato
Journal:  Malar J       Date:  2014-12-11       Impact factor: 2.979

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.